CD4 and neoplasm: Notably, in CT26-ULBP2 tumor-bearing mice, CD4+ T cell depletion did not significantly reduce tumor volume or weight on day 21 post-transplantation compared to isotype control antibody, and no complete regressions were observed (Figure 2I–K).